HOOKIPA Pharma Inc. (NASDAQ:HOOK) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough

Simply Wall StDec 21 07:00 ET

HOOKIPA Pharma Cut to Sector Perform From Outperform by RBC Capital

Dow JonesDec 20 09:21 ET · Ratings

RBC Downgrades HOOKIPA Pharma to Sector Perform From Outperform, Slashes Price Target to $2 From $48, Keeps Speculative Risk

MT NewswiresDec 20 06:17 ET · Ratings

Hookipa Pharma Price Target Lowered to $7 From $24 at JMP Securities

Yahoo FinanceNov 22 06:51 ET

Sector Update: Health Care Stocks Climb Thursday Afternoon

MT NewswiresNov 21 13:50 ET

HOOKIPA Pharma to Cut Workforce by 80%, Shift Focus to KRAS Cancer Program

MT NewswiresNov 21 07:42 ET